EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Refractory solar lentigines successfully treated with 532‐nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series

So Young Lee iD, Ka Ram Kim, Seunghyeon Kim, Hye Sung Han, Ji Yeon Hong, Joon Seok, Kui Young Park

Skin Research and Technology · 2024

DOI: 10.1111/srt.70055 ↗

At a glance

Journal article in Skin Research and Technology, 2024. Written by So Young Lee and 6 co-authors. Institution: Department of Dermatology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Major MEDLINE topics: Lasers, Solid-State, Lentigo. Cited 2 times so far (Crossref); 14 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Chung-Ang University Research Scholarship Grants in 2024, Technology Development Program-Material and component technology development project, Ministry of Trade, Industry & Energy.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Solar lentigo, a common epidermal hyperpigmented lesion found in sun‐exposed areas, results from the proliferation of melanocytes and the accumulation of melanin. Although various treatments for solar lentigo have been explored, they often lead to complications, including prolonged erythema and post‐inflammatory hyperpigmentation (PIH), posing significant concerns. Objectives and methods This study evaluated the safety and efficacy of the Vasculature Salvage Laser Surgery (VSLS) system. We treated six Korean patients, each with solar lentigo, in a single session using the 532‐nm nanosecond neodymium‐doped yttrium aluminum garnet (Nd:YAG) VSLS system, with follow‐up periods ranging from 3 to 10 weeks.

Results

The treatment led to the complete removal of pigmented lesions in all patients without resulting in PIH, even in cases where previous laser treatments had failed. The only side effect observed was mild erythema, which resolved over the long term in most instances.

Conclusions

The VSLS system emerges as a safe and effective treatment for pigmented lesions, including refractory solar lentigines. Nonetheless, additional studies are required to verify its long‐term efficacy.

Subjects

MeSH terms (MEDLINE)

Lasers, Solid-StateLentigoHumansFemaleMaleMiddle AgedAdultTreatment OutcomeAgedLaser TherapySunlightHyperpigmentation

Author keywords

Nd:YAG laserVSLS systempigmented lesionspostinflammatory hyperpigmentationsolar lentigo

Authors and institutions

  • Department of Dermatology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
  • Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si, Republic of Korea.

ORCID profiles: So Young Lee

Funding

  • Chung-Ang University Research Scholarship Grants in 2024
  • Technology Development Program-Material and component technology development project
  • Ministry of Trade, Industry & Energy

Cite

APA

Lee, S. Y., Kim, K. R., Kim, S., Han, H. S., Hong, J. Y., Seok, J., & Park, K. Y. (2024). Refractory solar lentigines successfully treated with 532‐nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series. Skin Research and Technology. https://doi.org/10.1111/srt.70055

Vancouver

Lee SY, Kim KR, Kim S, Han HS, Hong JY, Seok J, et al. Refractory solar lentigines successfully treated with 532‐nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series. Skin Research and Technology. 2024. doi:10.1111/srt.70055

BibTeX
@article{Lee2024,
  author = {Lee, So Young and Kim, Ka Ram and Kim, Seunghyeon and Han, Hye Sung and Hong, Ji Yeon and Seok, Joon and Park, Kui Young},
  title = {Refractory solar lentigines successfully treated with 532‐nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series},
  journal = {Skin Research and Technology},
  year = {2024},
  doi = {10.1111/srt.70055}
}
Start for free →